tizanidine

Generic: tizanidine

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name tizanidine
Generic Name tizanidine
Labeler asclemed usa, inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

tizanidine hydrochloride 4 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-866
Product ID 76420-866_259ac6fd-2a83-04c0-e063-6394a90af566
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA076286
Listing Expiration 2026-12-31
Marketing Start 2021-06-15

Pharmacologic Class

Classes
adrenergic alpha2-agonists [moa] central alpha-2 adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420866
Hyphenated Format 76420-866

Supplemental Identifiers

RxCUI
313412 313413
UNII
B53E3NMY5C

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tizanidine (source: ndc)
Generic Name tizanidine (source: ndc)
Application Number ANDA076286 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 4 mg/1
source: ndc
Packaging
  • 1000 TABLET in 1 BOTTLE (76420-866-00)
  • 120 TABLET in 1 BOTTLE (76420-866-12)
  • 150 TABLET in 1 BOTTLE (76420-866-15)
  • 30 TABLET in 1 BOTTLE (76420-866-30)
  • 60 TABLET in 1 BOTTLE (76420-866-60)
  • 90 TABLET in 1 BOTTLE (76420-866-90)
source: ndc

Packages (6)

76420-866-00 1000 TABLET in 1 BOTTLE (76420-866-00) 76420-866-12 120 TABLET in 1 BOTTLE (76420-866-12) 76420-866-15 150 TABLET in 1 BOTTLE (76420-866-15) 76420-866-30 30 TABLET in 1 BOTTLE (76420-866-30) 76420-866-60 60 TABLET in 1 BOTTLE (76420-866-60) 76420-866-90 90 TABLET in 1 BOTTLE (76420-866-90)

Ingredients (1)

tizanidine hydrochloride (4 mg/1)

Linked Drug Pages (1)

Tizanidine ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "259ac6fd-2a83-04c0-e063-6394a90af566", "openfda": {"unii": ["B53E3NMY5C"], "rxcui": ["313412", "313413"], "spl_set_id": ["81385ce2-1d82-4987-8e18-83c823e10b99"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "1000 TABLET in 1 BOTTLE (76420-866-00)", "package_ndc": "76420-866-00", "marketing_start_date": "20241029"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (76420-866-12)", "package_ndc": "76420-866-12", "marketing_start_date": "20241029"}, {"sample": false, "description": "150 TABLET in 1 BOTTLE (76420-866-15)", "package_ndc": "76420-866-15", "marketing_start_date": "20241029"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (76420-866-30)", "package_ndc": "76420-866-30", "marketing_start_date": "20241029"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (76420-866-60)", "package_ndc": "76420-866-60", "marketing_start_date": "20241029"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (76420-866-90)", "package_ndc": "76420-866-90", "marketing_start_date": "20241029"}], "brand_name": "Tizanidine", "product_id": "76420-866_259ac6fd-2a83-04c0-e063-6394a90af566", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha2-Agonists [MoA]", "Central alpha-2 Adrenergic Agonist [EPC]"], "product_ndc": "76420-866", "generic_name": "Tizanidine", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tizanidine", "active_ingredients": [{"name": "TIZANIDINE HYDROCHLORIDE", "strength": "4 mg/1"}], "application_number": "ANDA076286", "marketing_category": "ANDA", "marketing_start_date": "20210615", "listing_expiration_date": "20261231"}